| Application no. and date | 19213030.0 (espacenet) (Federated) (European Patent Register), 20130429 | | Patent/reg. no. and date | DK/EP 3677591, 20221228 | | Publication date | 20200708 | | Priority no. and date | | | EP pub. no. and date |
EP 3677591 20200708 | | Effective date | | | Applicant/owner | Teva Pharmaceuticals Australia Pty Ltd, Level 2
37 Epping Road
Macquarie Park, NSW 2113, AU | | Applicant ref. no. | PV1557DKEP | | Inventor | CLARKE, Adam, 37 Epping Road, Level 2 Macquarie Park
NSW 2113, AU,
POLLARD, Matthew, 37 Epping Road, Level 2 Macquarie Park
NSW 2113, AU,
DOYLE, Anthony, Gerard, 37 Epping Road, Level 2 Macquarie Park
NSW 2113, AU,
BEHRENS, Collette, 37 Epping Road, Level 2 Macquarie Park
NSW 2113, AU,
YAMAGISHI, Tetsuo, 37 Epping Road, Level 2 Macquarie Park
NSW 2113, AU,
WILSON, David, S. Jr., 610 Galveston Drive
Redwood City, California 94063, US,
POGUE, Sarah, L., 241 Barton Dr.
Fremont, California 94536-1703, US,
TAURA, Tetsuya, 514 Driscoll Place
Palo Alto, California 94306, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/21 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , C07K 14/56 (2006.01) , C07K 16/28 (2006.01) | | Title | Anti-CD38 antistoffer og fusioner til svækket interferon alpha-2b | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
